Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03284411 · ClinicalTrials.gov registry record · Phase 4
Spinal Cord Stimulation (SCS) Dosing Study
A Phase 4 study, sponsored by MedtronicNeuro.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT03284411 is a Phase 4 study that has completed, run by MedtronicNeuro. The registered enrollment target is 30 participants.
The verdict
NCT03284411, a Phase 4 study, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study characterized the effects of amplitude on subject satisfaction and pain relief in subjects being treated by SCS.
Interventions
- DEVICE Spinal Cord Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2019-03-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03284411
The ClinicalTrials.gov registry entry for NCT03284411 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Spinal Cord Stimulation is the first listed.
NCT03284411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03284411 about?
NCT03284411 is a clinical study titled "Spinal Cord Stimulation (SCS) Dosing Study". This study characterized the effects of amplitude on subject satisfaction and pain relief in subjects being treated by SCS.
What is the current status of trial NCT03284411?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2017-11-01. Estimated completion is 2019-03-15.
What interventions are being tested in trial NCT03284411?
The interventions under investigation include: Spinal Cord Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03284411?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.